Live feed07:00:00·73dPRReleasevia QuantisnowSpruce Biosciences Announces Positive Type B Meetings with U.S. FDA for TA-ERT for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)ByQuantisnow·Wall Street's wire, on your screen.SPRB· Spruce Biosciences Inc.Health Care
